BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 34320398)

  • 1. Maximum Standardized Uptake Value on Positron Emission Tomography is Associated With More Advanced Disease and High-risk Features in Lung Adenocarcinoma.
    Koike T; Sato N; Hosoda Y; Tazawa M; Goto T; Sato S; Yamazaki M; Toyabe SI; Tsuchida M
    Semin Thorac Cardiovasc Surg; 2022; 34(3):1051-1060. PubMed ID: 34320398
    [No Abstract]   [Full Text] [Related]  

  • 2. Prediction of pathologic node-negative clinical stage IA lung adenocarcinoma for optimal candidates undergoing sublobar resection.
    Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
    J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1365-71. PubMed ID: 22883546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multivariate analysis based on the maximum standard unit value of
    Wang Y; Lyu D; Zhou T; Tu W; Fan L; Liu S
    Diagn Interv Radiol; 2023 Mar; 29(2):379-389. PubMed ID: 36988049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour standardized uptake value on positron emission tomography is a novel predictor of adenocarcinoma in situ for c-Stage IA lung cancer patients with a part-solid nodule on thin-section computed tomography scan.
    Hattori A; Suzuki K; Matsunaga T; Fukui M; Tsushima Y; Takamochi K; Oh S
    Interact Cardiovasc Thorac Surg; 2014 Mar; 18(3):329-34. PubMed ID: 24351509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of a prognostic risk score that aggregates the FDG-PET/CT SUVmax, tumor size, and histologic group for predicting the prognosis of pStage I lung adenocarcinoma.
    Kawakita N; Toba H; Kawakami Y; Takizawa H; Bando Y; Otuska H; Matsumoto D; Takashima M; Tsuboi M; Yoshida M; Kondo K; Tangoku A
    Int J Clin Oncol; 2020 Jun; 25(6):1079-1089. PubMed ID: 32130543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score-matched analysis in a multicenter study.
    Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):358-64. PubMed ID: 23477694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of the combination of preoperative SUVmax and CEA in patients with clinical stage IA lung adenocarcinoma.
    Hashinokuchi A; Haratake N; Takenaka T; Matsudo K; Nagano T; Watanabe K; Kosai K; Oku Y; Ono Y; Takamori S; Kohno M; Baba S; Ishigami K; Yoshizumi T
    Thorac Cancer; 2022 Sep; 13(18):2624-2632. PubMed ID: 35962578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of CT and
    Li H; Li L; Liu Y; Deng Y; Zhu Y; Huang L; Long T; Zeng L; Shu Y; Peng D
    BMC Cancer; 2024 Apr; 24(1):434. PubMed ID: 38589832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impact of FDG-PET in surgically treated pathological stage I lung adenocarcinoma.
    Higuchi M; Hasegawa T; Osugi J; Suzuki H; Gotoh M
    Ann Thorac Cardiovasc Surg; 2014; 20(3):185-91. PubMed ID: 23603641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standardized Uptake Values in the Primary Lesions of Non-Small-Cell Lung Cancer in FDG-PET/CT Can Predict Regional Lymph Node Metastases.
    Nakamura H; Saji H; Marushima H; Kimura H; Tagaya R; Kurimoto N; Hoshikawa M; Takagi M
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1388-93. PubMed ID: 25900205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Outcomes After Sublobar Resection Versus Lobectomy in Patients With Clinical Stage IA Lung Adenocarcinoma Meeting the Node-Negative Criteria Defined by High-Resolution Computed Tomography and [
    Tsutani Y; Nakayama H; Ito H; Handa Y; Mimae T; Miyata Y; Okada M
    Clin Lung Cancer; 2021 May; 22(3):e431-e437. PubMed ID: 32665166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of Maximum Standard Uptake Value as a Predictor for Differentiating the Invasiveness of T1 Stage Pulmonary Adenocarcinoma.
    Fu L; Alam MS; Ren Y; Guan W; Wu H; Wang Q; Han Y; Zhou W; Li H; Wang Z
    Clin Lung Cancer; 2018 May; 19(3):221-229. PubMed ID: 29275041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Utility of SUVmax as an Adaptation Criterion for Limited Resection in Stage IA Non-Small Cell Lung Cancer.
    Motono N; Mizoguchi T; Ishikawa M; Iwai S; Iijima Y; Uramoto H
    Oncology; 2023; 101(8):473-480. PubMed ID: 37433283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of the Role of PET/CT SUVmax in Prognosis and Its Correlation with 
Clinicopathological Characteristics in Resectable Lung Squamous Cell Carcinoma].
    Ren H; Xu W; You J; Song X; Huang H; Zhao N; Ren X; Zhang X
    Zhongguo Fei Ai Za Zhi; 2016 Apr; 19(4):192-9. PubMed ID: 27118646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter analysis of high-resolution computed tomography and positron emission tomography/computed tomography findings to choose therapeutic strategies for clinical stage IA lung adenocarcinoma.
    Okada M; Nakayama H; Okumura S; Daisaki H; Adachi S; Yoshimura M; Miyata Y
    J Thorac Cardiovasc Surg; 2011 Jun; 141(6):1384-91. PubMed ID: 21440264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of preoperative FDG-PET in stage IA lung adenocarcinoma.
    Murakami S; Saito H; Sakuma Y; Kondo T; Oshita F; Ito H; Tsuboi M; Hasegawa C; Yokose T; Kameda Y; Nakayama H; Yamada K
    Eur J Radiol; 2012 Aug; 81(8):1891-5. PubMed ID: 21546177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationships between SUVmax of lung adenocarcinoma and different T stages, histological grades and pathological subtypes: a retrospective cohort study in China.
    Sun X; Chen T; Xie C; Liu L; Lei B; Wang L; Ruan M; Yan H; Zhang Q; Chang C; Xie W
    BMJ Open; 2022 May; 12(5):e056804. PubMed ID: 35580966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 18F-fluorodeoxyglucose positron emission tomographic scan in solid-type p-stage-I pulmonary adenocarcinomas: what can produce false-negative results?
    Lococo F; Galeone C; Formisano D; Bellafiore S; Filice A; Annunziata T; Cesario A; Rapicetta C; Fioroni F; Ricchetti T; Paci M
    Eur J Cardiothorac Surg; 2017 Apr; 51(4):667-673. PubMed ID: 28043987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occult mediastinal lymph node metastasis in FDG-PET/CT node-negative lung adenocarcinoma patients: Risk factors and histopathological study.
    Miao H; Shaolei L; Nan L; Yumei L; Shanyuan Z; Fangliang L; Yue Y
    Thorac Cancer; 2019 Jun; 10(6):1453-1460. PubMed ID: 31127706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose Uptake Values in Positron Emission Tomography Are Useful to Predict Survival after Sublobar Resection for Lung Cancer.
    Nakamura H; Saji H; Marushima H; Tagaya R; Kimura H; Takagi M
    Thorac Cardiovasc Surg; 2017 Mar; 65(2):150-157. PubMed ID: 26909560
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.